Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis

Seizure : the Journal of the British Epilepsy Association
J M KuijlenE A Beuls

Abstract

Thirty publications on the effectiveness of prophylactic antiepileptic drugs (AEDs) with supratentorial craniotomies were reviewed (1980-1995). After a first selection, six controlled studies remained (11 publications). These six were evaluated according to previously defined methodological criteria. The criteria were divided into three main categories: (1) internal validity, (2) proper and relevant outcome-measures and (3) analysis. In this way a maximum of 145 points could be obtained for each study. Three studies were considered to be of satisfactory methodological quality (> or = 55% or 145 points) and the odds ratios were calculated as a measure of association between treatment and occurrence of convulsions. The odds ratios of these three studies were statistically pooled using the Mantel-Haenszel Estimator. From this test it appeared that prophylactically used AEDs showed a tendency to prevent postoperative convulsions, but this effect was certainly not statistically significant (P = 0.1 one-tailed). Points of attention concerning possible future investigations are stressed.

References

Sep 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·P M FoyM D Shaw
Jan 1, 1992·Acta neurochirurgica·J BidzińskiA Sherif
Mar 1, 1992·Journal of Clinical Epidemiology·A S DetskyK A L'Abbé
Jan 1, 1990·Journal of Clinical Epidemiology·G ter RietP Knipschild
Jan 1, 1990·Acta neurochirurgica·S FranceschettiG Avanzini
Jan 1, 1989·British Journal of Neurosurgery·J B North
Sep 1, 1985·Neurosurgery·C S Deutschman, S J Haines
Mar 1, 1985·Neurosurgery·D J BoariniJ C VanGilder
Nov 1, 1986·Neurosurgery·I SbeihS A O'Laoire
Dec 1, 1985·Neurosurgery·T KeränenM Vapalahti
Jan 1, 1984·Acta neurochirurgica·L CalliauwL Verbeke
May 1, 1983·Journal of Neurosurgery·J B NorthW B Taylor
Apr 1, 1984·Journal of Neurosurgery·W F Bouzarth, H W Goldman
Jan 1, 1983·Acta neurochirurgica·M D ShawD Chadwick
Jan 1, 1983·Neurosurgery·D A KvamD O Quest
Jan 1, 1981·Acta neurochirurgica·P M FoyM D Shaw
Jan 1, 1981·Acta neurochirurgica·P M FoyM D Shaw
Nov 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·K OhnoS Monma
Apr 17, 1948·British Medical Journal·G J CLELAND

❮ Previous
Next ❯

Citations

May 26, 2005·Cancer Treatment Reviews·Konstantinos S PolyzoidisNicholas Pavlidis
Aug 17, 2004·Epilepsy Currents·Nancy R. Temkin
May 1, 2002·Current Opinion in Oncology·Patrick Y Wen, Peter W Marks
Jul 13, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R SoffiettiC Vecht
Dec 20, 2002·Clinical Pharmacokinetics·James H FischerPatricia A Fischer
Jun 14, 2000·Drugs·A Iudice, L Murri
Jan 16, 2004·Neurologia Medico-chirurgica·Shinya ManakaYoshiaki Mayanagi
Nov 3, 2012·Neurosurgical Focus·Judith M WongAtul A Gawande
Oct 26, 2005·Neurosurgical Focus·Fred G Barker, Bob S Carter
Apr 17, 2004·Journal of Neurosurgery·Kemal Yücesoy, Ercan Ozer
Feb 20, 2014·Asian Journal of Neurosurgery·Sankalp GokhaleDavid L McDonagh
Feb 18, 2014·Journal of Neuro-oncology·Shaheryar F AnsariJames C Miller
Apr 11, 2001·Journal of Neurosurgical Anesthesiology·P N Varelas, M A Mirski
Feb 26, 2008·European Journal of Anaesthesiology·M RadhakrishnanM N Subhash
Mar 5, 2013·Surgical Oncology Clinics of North America·Tannie HuangSusan M Chang
Sep 25, 2012·Annales Françaises D'anesthèsie Et De Rèanimation·N Engrand, D Osinski
Jun 13, 2012·Annales Françaises D'anesthèsie Et De Rèanimation·N Engrand
Nov 4, 2015·Neuro-oncology·Terri S ArmstrongAndrew D Norden
Jul 17, 2012·Hematology/oncology Clinics of North America·Jill LacyJames B Yu
Mar 24, 2012·Neurosurgery Clinics of North America·Dario J EnglotPaul A Garcia
Feb 5, 2008·Critical Care Clinics·Marek A Mirski, Panayiotis N Varelas
Jul 26, 2011·Annals of Neurology·Matthias PreusserRoger Stupp
Oct 18, 2007·Expert Review of Neurotherapeutics·Farrah N Daly, David Schiff
Apr 28, 2005·Expert Review of Neurotherapeutics·Ettore BeghiCesare Cornaggia
Jul 6, 2015·Current Treatment Options in Oncology·Jeffrey J Raizer, Karan S Dixit
Nov 2, 2014·Neuro-oncology·David SchiffPatrick Y Wen
May 10, 2013·Expert Review of Clinical Pharmacology·Jordi BrunaRoser Velasco
Nov 29, 2011·The Journal of International Medical Research·B ZhangH-Y Huang
Jul 29, 2017·Journal of Neurosurgery·Soliman OushyD Ryan Ormond
May 24, 2018·The Cochrane Database of Systematic Reviews·Janette GreenhalghAnthony G Marson
Jun 30, 2006·Journal of Neuro-oncology·Patrick Y WenLisa Doherty
Dec 14, 2019·Journal of Neuro-oncology·Brett E YoungermanJeffrey N Bruce
Jan 23, 2020·Cancer·L Nicolas Gonzalez Castro, Tracey A Milligan
Apr 29, 2020·The Cochrane Database of Systematic Reviews·Janette GreenhalghAnthony G Marson
Apr 22, 2008·The Cochrane Database of Systematic Reviews·I W Tremont-LukatsM R Gilbert
Jun 8, 2010·Journal of Neuro-oncology·Iris ZachenhoferKarl Roessler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.